{
    "clinical_study": {
        "@rank": "58647", 
        "acronym": "Fit", 
        "arm_group": [
            {
                "arm_group_label": "control (C) group", 
                "arm_group_type": "No Intervention", 
                "description": "The control group will remain in routine care for 12 weeks. After 12 weeks they will also be given a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre. During the next 12 weeks they will get care calls from the study centre aiming to discuss measured data and to fix target agreements."
            }, 
            {
                "arm_group_label": "telemedical (TM) group", 
                "arm_group_type": "Experimental", 
                "description": "Participants in the telemedical (TM) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre."
            }, 
            {
                "arm_group_label": "telemedical coaching (TMC) group", 
                "arm_group_type": "Experimental", 
                "description": "Participants in the telemedical coaching (TMC) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre. Additionally, they will be called once per week for 12 weeks from the study centre aiming to discuss measured data and to fix target agreements. After 12 weeks the care calls be be given once per month for further 9 months."
            }
        ], 
        "brief_summary": {
            "textblock": "Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching\n      have the potential to support lifestyle change and weight loss. Therefore, the aim of our\n      randomized controlled trial is to examine the effect of telemedicine with and without\n      coaching in comparison to a control group on weight loss in overweight participants."
        }, 
        "brief_title": "Telemedical Coaching for Weight Loss", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Overweight", 
            "Obesity", 
            "Metabolic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Weight Loss", 
                "Overweight", 
                "Metabolic Syndrome X"
            ]
        }, 
        "detailed_description": {
            "textblock": "In an occupational health care setting employees with overweight and/or metabolic syndrome\n      will be randomized into a three arm 12-week trial. Participants in the telemedical (TM) and\n      telemedical coaching (TMC) group got a weighing machine and a step counter, with automatic\n      transfer into a personalized online portal, which could be monitored from both, the\n      participant and the study centre. The TMC group weekly will get care calls from the study\n      centre aiming to discuss measured data and to fix target agreements. The control group will\n      remain in routine care."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  employed at Boehringer Ingelheim Pharma GmbH for at least 2 years\n\n          -  older than 40 years\n\n          -  overweight or obese or metabolic syndrome\n\n        Exclusion Criteria:\n\n          -  not willing to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01837134", 
            "org_study_id": "Telemedical coaching", 
            "secondary_id": "98149"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "telemedical (TM) group", 
                    "telemedical coaching (TMC) group"
                ], 
                "description": "telemedical devices (weighing machine and step counter)", 
                "intervention_name": "telemedical (TM) group", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "telemedical coaching (TMC) group", 
                "description": "care calls once per week for 12 weeks", 
                "intervention_name": "telemedical coaching (TMC) group", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "telemedicine", 
            "overweight", 
            "obesity"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "D\u00fcsseldorf", 
                    "country": "Germany", 
                    "zip": "40591"
                }, 
                "name": "West-German Centre of Diabetes and Health"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "TeleLifestyleCoaching Study - Telemedical Coaching for Weight Loss", 
        "other_outcome": {
            "description": "Eating behaviour will be measured using the validated questionnaire FEV.", 
            "measure": "eating behaviour", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "overall_official": {
            "affiliation": "West-German Centre of Diabetes and Health", 
            "last_name": "Stephan Martin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Weight will be measured at baseline and after 12 weeks.", 
            "measure": "weight loss", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01837134"
        }, 
        "responsible_party": {
            "investigator_affiliation": "West German Center of Diabetes and Health", 
            "investigator_full_name": "Stephan Martin", 
            "investigator_title": "Director of the West German Center of Diabetes and Health", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "cardiometabolic risk factors", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Quality of life will be assessed by the validated questionnaires ADS-L and SF-12.", 
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Physical activity will be assessed using a validated questionnaire.", 
                "measure": "physical activity", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "West German Center of Diabetes and Health", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "West German Center of Diabetes and Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}